Much of Europe might be experiencing austerity, but some family businesses are reporting strong growth.
A German family-owned pharmaceutical company, Boehringer Ingelheim, said on 24 April that revenues for 2011 rose by 6.2% to €13.2 billion.
Much of this growth was due to the sale of prescription medicines, which accounted for 77% of total turnover, said the Ingelheim-based group.